This is a double-blind, placebo-controlled human laboratory clinical pharmacology study to assess potential interactions between intravenous d-methamphetamine infusion and treatment with oral aripiprazole.
The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.